Skye Bioscience, Inc. Research And Development Expense

Quick Answer

Skye Bioscience, Inc. reported Research And Development Expense of $6.01 million for the year ending 2022.

  • Skye Bioscience, Inc. showed an increase of +105.1% in Research And Development Expense from 2021 to 2022.
  • This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2023.
  • XBRL data for this metric is available from 2014 to 2022 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2014 to 2022), Skye Bioscience, Inc.'s Research And Development Expense has grown by 2,542.6%.
  • Historical annual values: Fiscal year 2022: $6.01 million | Fiscal year 2021: $2.93 million | Fiscal year 2020: $1.94 million | Fiscal year 2019: $2.24 million | Fiscal year 2018: $330.0 thousand | Fiscal year 2017: $311.3 thousand | Fiscal year 2016: $939.0 thousand | Fiscal year 2015: $576.1 thousand | Fiscal year 2014: $227.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: